Compare Lustrum:TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.:4581

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. 4581 Medicals 東証スタンダード March 1, 2000 2011.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet 2023年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet 2022年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet 2021年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet 2020年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
255,966down
(27.2%)down
265,049up
(29.8%)up
250,178up
(28.5%)up
223,814down
(25.9%)down
282,567
(34.4%)
Other Current AssetsHelp
(Percent)
119,914up
(12.7%)down
113,815up
(12.8%)up
107,553down
(12.3%)down
131,809down
(15.2%)down
187,214
(22.8%)
Tangible Fixed AssetsHelp
(Percent)
141,170up
(15.0%)up
119,291up
(13.4%)up
113,194up
(12.9%)down
112,648up
(13.0%)up
91,283
(11.1%)
Intangible Fixed AssetHelp
(Percent)
110,441up
(11.7%)up
87,290down
(9.8%)down
87,920down
(10.0%)down
88,642up
(10.2%)up
11,768
(1.4%)
Investments and OthersHelp
(Percent)
185,948up
(19.8%)down
176,945down
(19.9%)down
189,466up
(21.6%)up
174,892down
(20.2%)down
236,416
(28.8%)
Total AssetsHelp
(Percent)
941,490
(100%)
888,159
(100%)
876,923
(100%)
864,974
(100%)
821,782
(100%)
Total Current LiabilitiesHelp
(Percent)
154,125up
(16.4%)up
138,794down
(15.6%)down
146,413down
(16.7%)down
153,534up
(17.8%)up
108,810
(13.2%)
Total Long-term LiabilitiesHelp
(Percent)
798down
(0.1%)down
1,214up
(0.1%)up
1,004down
(0.1%)down
1,292
(0.1%)
0
-
Shareholder's EquityHelp
(Percent)
786,567up
(83.5%)down
748,151up
(84.2%)up
729,506up
(83.2%)up
710,148down
(82.1%)down
712,972
(86.8%)
Total LiabilitiesHelp
(Percent)
941,490
(100%)
888,159
(100%)
876,923
(100%)
864,974
(100%)
821,782
(100%)

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account 2023年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account 2022年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account 2021年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account 2020年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
301,381
(100%)
268,203
(100%)
281,980
(100%)
288,527
(100%)
261,551
(100%)
Total Sales
(Percent)
301,381
(100%)
268,203
(100%)
281,980
(100%)
288,527
(100%)
261,551
(100%)
Cost of SalesHelp
(Percent)
123,531up
(41.0%)up
104,371down
(38.9%)up
106,050down
(37.6%)up
108,386up
(37.6%)up
91,206
(34.9%)
Other Costs and RevenueHelp 158,853up
(52.7%)down
150,710down
(56.2%)down
162,614up
(57.7%)up
159,967up
(55.4%)up
121,750
(46.5%)
Total CostsHelp 282,384 255,081 268,664 268,353 212,956
Net RevenueHelp 177,850up
(59.0%)down
163,832down
(61.1%)down
175,930down
(62.4%)down
180,141up
(62.4%)down
170,345
(65.1%)
Earnings Before TaxHelp 29,498up
(9.8%)up
21,398down
(8.0%)down
22,976down
(8.1%)down
29,775down
(10.3%)down
64,484
(24.7%)
Net IncomeHelp 18,997up
(6.3%)up
13,122down
(4.9%)up
13,316down
(4.7%)down
20,174down
(7.0%)down
48,595
(18.6%)
当期純利益 18,997 13,122 13,316 20,174 48,595

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement 2023年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement 2022年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement 2021年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement 2020年3月期 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
40,972up
(96.3%)down
28,506down
(97.3%)down
42,026up
(100.0%)up
41,993up
(35.4%)up
19,178
(22.5%)
Investing Cash Flow(ICF)Help
(Percent)
-27,130down
(-63.7%)down
-7,063down
(-24.1%)down
-1,958up
(-4.7%)up
-107,081down
(-90.2%)down
66,044
(77.5%)
Financing Cash FlowHelp
(Percent)
-10,877down
(-25.6%)up
-10,057up
(-34.3%)down
-11,346up
(-27.0%)down
-11,696up
(-9.8%)up
-15,467
(-18.1%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
1,595up
(3.7%)up
780up
(2.7%)up
-317down
(-0.8%)down
177up
(0.1%)up
-570
(-0.7%)
Net Increase and Decrease in Cash and Cash Equivalentsn 4,560down
(10.7%)down
12,166down
(41.5%)down
28,405up
(67.6%)up
-76,607down
(-64.5%)down
69,185
(81.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.

Company where related level is highHelp

TSUMURA & CO.
Daito Pharmaceutical Co.,Ltd.
Oncolys BioPharma Inc.
TAIKO PHARMACEUTICAL CO.,LTD.
AnGes,Inc.
EIKEN CHEMICAL CO.,LTD.
FunPep Company Limited
ROHTO PHARMACEUTICAL CO.,LTD.
ONO PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Holdings Co., Ltd.